Shanghai Lai Shi stock is a stock issued and listed by Shanghai Lai Shi Blood Products Co., Ltd. through Shenzhen Stock Exchange. The stock belongs to the securities category of A shares on the main board of Shenzhen Stock Exchange. The stock code is 002252. The core theme is the production and sales of blood products and the overall scale advantage.

Shanghai Laishi Blood Products Co., Ltd. was established on 1988, and was listed on the small and medium-sized board of Shenzhen Stock Exchange in 2008. Is a well-known blood products enterprise in Asia. Its main products include human albumin, human immunoglobulin, intravenous immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin and rabies immunoglobulin.